Validation of a new cancer-related VTE model

Published Date: 02 Mar 2023

The ONKOTEV score predicts the risk of venous thromboembolism in cancer patients.

Read Full News

Latest News

Weight-Loss Drugs Reduce Muscle More Than Expected

Losing muscle mass is not the same as losing muscle strength and function, clinicians say.

BP Below 120 mm Hg Achievable in Patients at High Risk

Targeting systolic blood pressure below 120 mm Hg is achievable in most patients with hypertension and a high cardiovascular risk, including those with long-standing uncontrolled blood pressure.

Impella No Help in MI Without Shock

STEMI patients without cardiogenic shock treated with a microaxial flow pump and a 30-minute delay in PCI have no less heart muscle damage than those who undergo immediate revascularization.

Osimertinib Maintains QOL Post-Chemoradiotherapy in NSCLC

Osimertinib maintains health-related quality of life and functioning in patients with unresectable stage III lung cancer after definitive chemoradiotherapy.

Low-Dose Aspirin May Reduce Cardiovascular Risk in GCA

Low-dose aspirin initiated at diagnosis of giant cell arteritis is linked to a reduced probability of major adverse cardiovascular events at 1 year but also to an increased risk for major hemorrhage.

Discoid Lupus: Hydroxychloroquine Linked to Lower CV Risk

Early use of hydroxychloroquine in adults with isolated discoid lupus is linked to lower 5-year rates of hyperlipidemia, coronary artery disease, and stroke, a study shows.

Todays Updates

Can Oncotype Predict Recurrence Risk in Older BC Patients?

A recent study assesses whether Oncotype DX can predict local recurrence risk in older, lower-risk patients with breast cancer who omit adjuvant radiation.

Todays Updates

Can Oncotype Predict Recurrence Risk in Older BC Patients?

A recent study assesses whether Oncotype DX can predict local recurrence risk in older, lower-risk patients with breast cancer who omit adjuvant radiation.

Latest News

Losing muscle mass is not the same as losing muscle strength and function, clinicians say.

Targeting systolic blood pressure below 120 mm Hg is achievable in most patients with hypertension and a high cardiovascular risk, including those with long-standing uncontrolled blood pressure.

STEMI patients without cardiogenic shock treated with a microaxial flow pump and a 30-minute delay in PCI have no less heart muscle damage than those who undergo immediate revascularization.

Osimertinib maintains health-related quality of life and functioning in patients with unresectable stage III lung cancer after definitive chemoradiotherapy.

Low-dose aspirin initiated at diagnosis of giant cell arteritis is linked to a reduced probability of major adverse cardiovascular events at 1 year but also to an increased risk for major hemorrhage.

Early use of hydroxychloroquine in adults with isolated discoid lupus is linked to lower 5-year rates of hyperlipidemia, coronary artery disease, and stroke, a study shows.

News All Time

Direct Oral Anticoagulants Linked to Fewer Brain Bleeds

The use of direct oral anticoagulants is linked to fewer intracerebral haemorrhage than the use of vitamin K antagonists, without an increase in the incidence of haemorrhage at the population level.

SGLT2 Inhibitors Linked to Lower Gout Medication Need in T2D

SGLT2 inhibitors may reduce gout flares and decrease the need for urate-lowering and acute gout medications in adults with both gout and type 2 diabetes.

Do Stabilisation Admissions Support Eating Disorder Care?

More than half of children and young people admitted for medical stabilisation of restrictive eating disorders continue recovery through outpatient care, although many require nutritional support.

AI Mammography Flags Cardiovascular Risk

AI can quantify breast arterial calcifications on routine mammograms and flag women with higher cardiovascular risk, enabling opportunistic heart disease screening.

Common Kitchen Herbs May Help Prevent Obesity

Common culinary herbs such as cress, coriander, sage, and mint may help prevent and manage obesity by reducing inflammation, improving metabolic health, and supporting gut microbiota.

Insurers Fail to Get Specific on Prior Authorization Reforms

An industry trade group says prior authorization requirements have declined by 11% after last year’s pledge, but the numbers are fuzzy.

Tirzepatide Bests Semaglutide in 12-Month Real-World Study

Tirzepatide is associated with a greater mean percent body weight reduction than semaglutide in adults with obesity or overweight and one or more related complications.

Long COVID May Increase Your Heart Disease Risk

Individuals with long COVID face a substantially higher risk of developing cardiovascular disease — particularly cardiac arrhythmias and coronary artery disease — than those without long COVID.

MHRA Approves Olezarsen for Rare Lipid Disorder

The MHRA has approved olezarsen for familial chylomicronaemia syndrome, a rare disorder linked to life-threatening pancreatitis.

Lower LDL-C Target May Improve CV Outcomes

A study finds direct evidence to support guideline changes that promote lower targets for low-density lipoprotein cholesterol.

BP Lower Than Target in Many With Coronary Heart Disease

Over one third of patients with coronary heart disease have blood pressure below targets recommended by European guidelines and have elevated risks for heart and kidney diseases.

Surgery Benefits Heart Health in Mild Cortisol Excess

In patients with mild autonomous cortisol secretion, adrenalectomy provides comprehensive cardiovascular benefits, improving blood pressure, cardiac structure, and coagulation profile.

Does Pregnancy Loss Signal Future Heart Disease?

A history of stillbirth or miscarriage is linked to an increased risk for cardiovascular disease in women.

Can Remote Pressure Monitoring Lower HF Hospitalisation?

A wireless implantable device that remotely monitors pulmonary artery pressure offers reliable safety and is linked to a significant reduction in the risk for heart failure-related hospitalisation.

Exercise Intensity Over Volume Linked to Lower Disease Risks

Higher intensity of physical activity, regardless of total volume, is linked to significantly lower risks for many cardiovascular and other chronic diseases and death.

Genetic Risk Tied to Postpartum BP Risk, BMI Matters More

First-time mothers with high genetic risk for systolic blood pressure have a higher likelihood of postpartum hypertension, but BMI and hypertensive pregnancy disorders are stronger risk factors.

Recommended News For You

Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study

FDA Expands Approval of Osimertinib in Lung Cancer

In breast cancer patients with nodes positive, preoperative hydroxyprogesterone may enhance disease-free survival.

La interacción GBP3-STING en el glioblastoma coordina la respuesta deficiente al temozolomide.

Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesothelioma

Adjuvant Tx May Boost Survival in Bilateral Breast Cancer

Could the Prostate Cancer Story of Francis Collins Dissuade Men from Active Surveillance?

Recommended Articles For You

KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer 

Understanding SVR Normal Range: A Guide to Achieving Optimal Health 

Cemiplimab: A Revolutionary Drug For Treating Cancer 

Revolutionizing Cancer Care: The Transformative Role of AI and Data Science in Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.

2.

Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer

3.

Encounters matter in cancer care: Health care professionals can play a key role in restoring patients' sense of control

4.

Cancer care crowdfunding increasingly common, but rarely successful

5.

Q&A: Researchers discuss identifying potential new protein targets for melanoma therapeutics

1.

IGSF8: A Rising Star in Cancer Immunotherapy - Harnessing the Innate Immune System

2.

Unlocking the Secrets of Blood Production: The Journey and Regulation of Hematopoietic Stem Cells

3.

CAR T + Ibrutinib in R/R Mantle Cell Lymphoma: Phase 2 TARMAC Study Insights

4.

Beyond the Biopsy: The Evolving Landscape of Prostate Cancer Management

5.

Unpacking Chordoma: Understanding the Rare Cancer and its Treatment Options 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Updates on the First Line Management of ALK+ NSCLC

2.

Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC

3.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

4.

Efficient Management of First line ALK-rearranged NSCLC - Part VI

5.

Navigating the Complexities of Ph Negative ALL - Part XII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot